Medical Science Liaison, Oncology

Field-based Medical Science Liaison in Oncology providing scientific support, education, and patient recruitment assistance to clinical trial sites across Italy,

IQVIA is seeking a scientifically credible and field-based Medical Science Liaison. You’ll be the key scientific point of contact for clinical trial sites—supporting site engagement, education, and patient recruitment across a diverse and impactful region. Location: Field-based – Italy Territory: Italy, Israel, Turkey, and Greece Ready to make a...

Medical Science Liaison Pediatric Oncology - Italy Want a 3D Career? Join Norgine. At Norgine, our colleagues Dare themselves to be different and try new things, Drive to achieve their goals and beyond, and Develop themselves and their community. We call it the 3D career at Norgine and it offers you a fully‑rounded experience with no limits. Bring...

Revolution Medicines in Italy seeks a Medical Science Liaison who will build and maintain relationships with KOLs, healthcare professionals and academic centers to advance scientific and medical knowledge while representing the company’s oncology portfolio. Ha le carte in regola per avere successo? Le seguenti informazioni devono essere lette attentamente...

Recordati cerca una figura per l'informazione scientifica rivolta a medici e operatori sanitari, illustrando proprietà farmacologiche e terapeutiche dei prodotti del portfolio aziendaleLa risorsa opererà sul territorio di Avellino, Benevento e parte di Napoli e Salerno, mantenendo relazione professionale con stakeholder sanitari e aggiornando costantemente...

Alfasigma is a privately held global healthcare company founded over 75 years ago in Italy, where it remains headquartered today in Bologna and Milan. The Group operates in over 100 markets spanning Europe, North and South America, Asia, and Africa. I candidati sono invitati a leggere attentamente tutti gli elementi di questo annuncio. La preghiamo di...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri‑complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly...